Avian Influenza: Information for Health Professionals and Laboratorians | Avian Influenza (Flu)

Avian Influenza: Information for Health Professionals and Laboratorians | Avian Influenza (Flu)

Avian Influenza: Information for Health Professionals and Laboratorians

CDC is currently updating some avian influenza guidance documents, which will be posted to this page as they are finalized. Where only avian H7N9 guidance is available, it is appropriate to use avian H7N9 guidance to address other avian influenza infections in people.

Testing and Reporting

• New! Interim Guidance on Testing, Specimen Collection, and Processing for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans
• Interim Guidance for Specimen Collection, Processing, and Testing for Patients with Suspected Infection with Novel Influenza A VirusesAssociated with Severe Disease in Humans
• Diagnostics for Detecting H7N9 Using rRT-PCR

Infection Control

• Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease

HAN: CDC Health Advisories

H5N1

• Human Infection with Avian Influenza A (H5N1) Virus January 15, 2014

H7N9

• CDC Health Alert Network (HAN) Update, Human Infections with Avian Influenza A (H7N9) Viruses June 7, 2013
• CDC Health Alert Network (HAN) Human Infections with Novel Influenza A (H7N9) Viruses April 5, 2013

Vaccine Development

H5N1

• Candidate vaccine viruses and potency testing reagents for influenza A (H5N1), WHO

H7N9

• Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses, WHO
• Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus[PDF, 604 KB]

Case Definitions

H5N1

• Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus in the United States January 13, 2014

H7N9

• Interim Guidance on Case Definitions for Investigations of Human Infection with Avian Influenza A (H7N9) Virus in the United States January 13, 2014

Treatment and Prophylaxis

Treatment

• New! Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease

Chemoprophylaxis of Persons with Bird Exposure

• New! Interim Guidance on Influenza Antiviral Chemoprophylaxis of Persons Exposed to Birds with Avian Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease

Chemoprophylaxis of Close Contacts

• New! Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis

Laboratorians

• CDC and USDA Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses
• World Health Organization (WHO) Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A(H7N9) virus causing human disease Interim recommendations[PDF, 74 KB]

CDC Expert Commentary on Medscape

Title: The New Avian Influenza A (H7N9) Virus: What Clinicians Should Know
Posting Date: Thursday, May 09, 2013
Faculty: Alicia M. Fry, MD, MPH